Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Luoxin Pharmaceutical (Shanghai) Co., Ltd.

Fujian Akeylink Biotechnology Co., Ltd.

Genfleet Therapeutics (Shanghai) Inc.

Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory

Genfleet Therapeutics Inc.

Luoxin Pharmaceutical Co., Ltd.

Shenyi Shi

Charles Z Ding

Lihong Hu

Jianyu Lu

Huijun He

Weidong Li

Jiaqiang Dong

Jian Li

Shuhui Chen

Zheng Wang

Fei Sun

Tie-Lin Wang

Bin Shi

Lifang Wu

Guanghai Xu

Qingqing Lu

Yanbin Hu

Shujie Yuan

Tiezhong Bai

Zhengwu Li

Qiaofen Hu

Yijie Cao

Jing Gao

Hui Ding

Jinhua Li

Xin Jin

Zhijuan Chen

Wenqian Yang

Yanxiao Su

The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the crystal form in preparing the hepatitis B surface antigen inhibitor.

Crystal form of hepatitis B surface antigen inhibitor

Provided are a salt form of an estrogen receptor down-regulator, a crystalline form thereof, and a preparation method therefor

Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor

Disclosed in the present invention are a crystal form and salt form of a TGF-&#x3b2;R1 inhibitor and a preparation method therefor, and further disclosed is an application of the crystal form and the salt form in preparation of medicines for treating cancers. 

Crystal form and salt form of TGF-&#x3b2;RI inhibitor and preparation method therefor

The present invention discloses to a hydrochloride salt, a citrate salt, a phosphate salt or a sulfate salt of compound 1, the crystal forms of the aforementioned salts, and a preparation method thereof. The present invention also relates their use in the preparation of a medicament for the treatment of cerebral apoplexy or epilepsy. 

Salts and crystal forms of diaza-benzofluoranthrene compounds

Disclosed are a crystal form of an estrogen receptor inhibitor and a preparation method therefor, in particular disclosed are a crystal form A of a compound of formula (I) and a preparation method therefor, and the use of the crystal form in the preparation of a drug for treating breast cancer. 

Crystal form of estrogen receptor inhibitor and preparation method therefor

Growing community of inventors

Shanghai, China

Shenyi Shi